ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Specialist

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

14,110Medicare Part D Prescriptions Filled, Including Refills

Rank: 30 out of 1290

$908K Total Retail Price of All Prescriptions

Rank: 61 out of 1290

454 Patients Receiving at Least One Drug in Part D
84%Patients 65 Years and Older
79% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Florida
Lower avg

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

3% of this provider’s 454 patients filled at least one prescription for a schedule three drug, compared to an average of 9%.

Risky Drugs to Seniors

1% of this provider’s 12,401 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

34% of this provider’s prescriptions were for brand-name drugs, compared to an average of 29%.

Prescription Price

$64 was the average price of a prescription from this provider, compared to $94 among peers.

Prescriptions per Patient

31 is the average number of prescriptions (including refills) per patient, compared to an average of 9.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Florida
CRESTOR 521 420 1 17
SIMVASTATIN 446 413 2 1
POTASSIUM CHLORIDE 395 343 3 35
LEVOTHYROXINE SODIUM 392 359 4 4
OMEPRAZOLE 349 326 5 2
IBUPROFEN 332 253 6 74
METFORMIN HCL 312 281 7 10
CARVEDILOL 283 243 8 12
LISINOPRIL 274 234 9 5
CLOPIDOGREL 264 216 10 24
NEXIUM 249 212 11 34
AMLODIPINE BESYLATE 246 222 12 3
FUROSEMIDE 240 220 13 9
LOSARTAN-HYDROCHLOROTHIAZIDE 233 207 14 106
FLUTICASONE PROPIONATE 229 187 15 26
PLAVIX 220 200 16 32
METOPROLOL TARTRATE 201 159 17 7
METOPROLOL SUCCINATE 200 173 18 14
PANTOPRAZOLE SODIUM 199 170 19 48
TAMSULOSIN HCL 196 184 20 11
LOSARTAN POTASSIUM 181 158 21 19
ATORVASTATIN CALCIUM 164 136 22 23
LISINOPRIL-HYDROCHLOROTHIAZIDE 162 157 23 92
DONEPEZIL HCL 160 160 24 13
FAMOTIDINE 146 123 25 128
ADVAIR DISKUS 143 134 26 37
TEMAZEPAM 139 133 27 71
LANSOPRAZOLE 133 119 28 181
ALPRAZOLAM 131 121 29 47
RANITIDINE HCL 126 114 30 49
ATENOLOL 122 104 31 18
ENALAPRIL MALEATE 118 113 32 62
ALENDRONATE SODIUM 117 113 33 39
LOVAZA 113 100 34 131
ZOLPIDEM TARTRATE 108 97 35 15
MELOXICAM 103 89 36 31
DIOVAN 99 95 37 53
SINGULAIR 96 79 38 85
GLYBURIDE-METFORMIN HCL 95 94 R 39 147
LANTUS 94 94 40 67
LYRICA 93 69 41 94
DIGOXIN 92 82 42 51
SYMBICORT 92 85 42 109
CLONIDINE HCL 88 83 44 66
ISOSORBIDE MONONITRATE ER 87 87 45 58
GABAPENTIN 83 47 46 8
VOLTAREN 80 75 47 107
ATENOLOL-CHLORTHALIDONE 75 74 48 339
FINASTERIDE 74 74 49 40
PRADAXA 73 64 50 179
DIOVAN HCT 73 66 50 112
CIALIS 72 64 52 230
AMMONIUM LACTATE 69 67 53 276
CLOTRIMAZOLE-BETAMETHASONE 69 67 53 153
ACTONEL 67 67 55 207
HYDROCHLOROTHIAZIDE 66 43 56 20
MECLIZINE HCL 66 55 56 159
GLIMEPIRIDE 63 60 58 57
JANUVIA 63 55 58 82
ACTOS 61 51 60 182
FOLIC ACID 61 54 60 188
LACTULOSE 60 57 62 254
LOVASTATIN 60 60 62 45
SERTRALINE HCL 60 49 62 36
INSULIN SYRINGE 57 56 65 76
KLOR-CON 10 55 51 66 291
DEXILANT 55 34 66 184
AMLODIPINE BESYLATE-BENAZEPRIL 55 41 66 166
SPIRIVA 55 44 66 75
CYMBALTA 54 38 70 59
CLONAZEPAM 53 50 71 170
ONGLYZA 53 46 71 263
DICLOFENAC SODIUM 51 46 73 77
AGGRENOX 50 50 74 308
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Feb. 16, 2012.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.